ZA973190B - Fast melting oral dosage form. - Google Patents

Fast melting oral dosage form.

Info

Publication number
ZA973190B
ZA973190B ZA9703190A ZA973190A ZA973190B ZA 973190 B ZA973190 B ZA 973190B ZA 9703190 A ZA9703190 A ZA 9703190A ZA 973190 A ZA973190 A ZA 973190A ZA 973190 B ZA973190 B ZA 973190B
Authority
ZA
South Africa
Prior art keywords
dosage form
pct
date oct
oral dosage
sec
Prior art date
Application number
ZA9703190A
Other languages
English (en)
Inventor
Pierre Humbert-Droz
Matthias Seidel
Rosa Martani
Original Assignee
Novartis Consumer Health Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Consumer Health Sa filed Critical Novartis Consumer Health Sa
Publication of ZA973190B publication Critical patent/ZA973190B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA9703190A 1996-04-16 1997-04-15 Fast melting oral dosage form. ZA973190B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP96810236 1996-04-16

Publications (1)

Publication Number Publication Date
ZA973190B true ZA973190B (en) 1997-12-17

Family

ID=8225590

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9703190A ZA973190B (en) 1996-04-16 1997-04-15 Fast melting oral dosage form.

Country Status (12)

Country Link
US (1) US6083531A (fr)
EP (1) EP0893992B1 (fr)
JP (1) JP2000508649A (fr)
AT (1) ATE260646T1 (fr)
AU (1) AU2636797A (fr)
DE (1) DE69727922T2 (fr)
DK (1) DK0893992T3 (fr)
ES (1) ES2217410T3 (fr)
PT (1) PT893992E (fr)
TR (1) TR199802068T2 (fr)
WO (1) WO1997038679A2 (fr)
ZA (1) ZA973190B (fr)

Families Citing this family (75)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2322315C (fr) * 1998-03-06 2008-09-16 Eurand International S.P.A. Comprime a desintegration rapide
US6465009B1 (en) * 1998-03-18 2002-10-15 Yamanouchi Pharmaceutical Co., Ltd. Water soluble polymer-based rapidly dissolving tablets and production processes thereof
US7022683B1 (en) 1998-05-13 2006-04-04 Carrington Laboratories, Inc. Pharmacological compositions comprising pectins having high molecular weights and low degrees of methoxylation
SK288117B6 (sk) * 1998-11-20 2013-09-03 Skyepharma Canada Inc. Rapidly dispersing solid dry therapeutic dosage form
GB9908014D0 (en) * 1999-04-08 1999-06-02 Scherer Corp R P Pharmaceutical compositions
AU765526B2 (en) * 1999-08-17 2003-09-18 Novartis Consumer Health S.A. Rapidly dissolving dosage form and process for making same
AU2001281846B2 (en) * 2000-06-27 2006-04-27 Cheplapharm Arzneimittel Gmbh Method for preparing a composition
US7799342B2 (en) 2000-12-06 2010-09-21 Wyeth Llc Fast dissolving tablet
US6733781B2 (en) * 2000-12-06 2004-05-11 Wyeth Fast dissolving tablet
IN192750B (fr) * 2000-12-15 2004-05-15 Ranbaxy Lab Ltd
US6544557B2 (en) 2001-01-09 2003-04-08 Pan Pharmaceutical Limited Effervescent tablet compositions
US7494669B2 (en) * 2001-02-28 2009-02-24 Carrington Laboratories, Inc. Delivery of physiological agents with in-situ gels comprising anionic polysaccharides
US6777000B2 (en) * 2001-02-28 2004-08-17 Carrington Laboratories, Inc. In-situ gel formation of pectin
FR2833173B1 (fr) * 2001-12-10 2004-08-27 Roquette Freres Preparation antipyretique renfermant du xylitol
US20030148818A1 (en) * 2002-01-18 2003-08-07 Myrhum Mark C. Golf club woods with wood club head having a selectable center of gravity and a selectable shaft
EP1485296B1 (fr) * 2002-02-13 2011-07-20 Michael K. Weibel Forme posologique medicamenteuse et procede de fabrication
ES2285233T3 (es) 2002-12-20 2007-11-16 Niconovum Ab Un material en particulas que contiene nicotina y celulosa microcristalina fisicamente y quimicamente estable.
US20040156894A1 (en) * 2003-02-07 2004-08-12 Grother Leon Paul Use of edible acids in fast-dispersing pharmaceutical solid dosage forms
FR2857263B1 (fr) * 2003-07-09 2005-09-09 Sanofi Synthelabo Nouvelle composition pharmaceutique solide comprenant de l'amisulpride
US7390503B1 (en) 2003-08-22 2008-06-24 Barr Laboratories, Inc. Ondansetron orally disintegrating tablets
US7282217B1 (en) 2003-08-29 2007-10-16 Kv Pharmaceutical Company Rapidly disintegrable tablets
GB0320854D0 (en) 2003-09-05 2003-10-08 Arrow No 7 Ltd Buccal drug delivery
BRPI0414787B1 (pt) * 2003-09-24 2018-04-03 Novartis Consumer Health S.A. Comprimidos revestidos por filme
WO2005044006A1 (fr) * 2003-11-05 2005-05-19 Battelle Memorial Institute Dissolution rapide de produits agrochimiques
US8627828B2 (en) 2003-11-07 2014-01-14 U.S. Smokeless Tobacco Company Llc Tobacco compositions
US8469036B2 (en) 2003-11-07 2013-06-25 U.S. Smokeless Tobacco Company Llc Tobacco compositions
ATE516019T1 (de) * 2004-05-11 2011-07-15 Egalet Ltd Quellbare dosierform mit gellan-gummit
US20060134210A1 (en) * 2004-12-22 2006-06-22 Astrazeneca Ab Solid dosage form comprising proton pump inhibitor and suspension made thereof
US7992575B2 (en) * 2005-02-28 2011-08-09 U.S. Smokeless Tobacco Company Use of chlorate, sulfur or ozone to reduce tobacco specific nitrosamines
IS7724A (is) 2005-03-02 2006-09-03 Actavis Group Samsetning á töflum með hraða sundrun sem innihalda þungt magnesíum karbónat
JO3352B1 (ar) * 2005-06-17 2019-03-13 Apr Applied Pharma Res Sa صيغ دايكلوفيناك وطرق استخدامه
GB0516604D0 (en) * 2005-08-12 2005-09-21 Sandoz Ag Rapidly dispersing/disintegrating compositions
KR100702069B1 (ko) 2005-10-31 2007-03-30 (주)이엘티사이언스 파라세타몰 경구용 수용산제 복합조성물 및 그 제조방법
US7811604B1 (en) 2005-11-14 2010-10-12 Barr Laboratories, Inc. Non-effervescent, orally disintegrating solid pharmaceutical dosage forms comprising clozapine and methods of making and using the same
US9402809B2 (en) 2006-03-16 2016-08-02 Niconovum Usa, Inc. Snuff composition
US20100055179A1 (en) * 2006-12-21 2010-03-04 Mallinckrodt Inc. Composition of and Method for Preparing Orally Disintegrating Tablets Containing a High Dose of Pharmaceutically Active Ingredients
ES2302650B1 (es) 2007-01-11 2009-02-16 Tedec-Meiji Farma, S.A. Composicion de rapida desintegracion en la cavidad bucal.
GB0709541D0 (en) * 2007-05-17 2007-06-27 Jagotec Ag Pharmaceutical excipient
US9271524B1 (en) 2007-09-07 2016-03-01 U.S. Smokeless Tobacco Company Tobacco having reduced tobacco specific nitrosamine content
AU2008318851B2 (en) 2007-10-31 2014-04-17 Mcneil-Ppc, Inc. Orally disintegrated dosage form
MX2010009493A (es) * 2008-02-28 2010-12-20 Rp Scherer Technologies Llc Proceso para minimizar el polimorfismo.
EP2133071A1 (fr) * 2008-06-09 2009-12-16 Université de la Méditerranée Procédé pour fabriquer des formes de dosage de rétention gastrique
FR2933959B1 (fr) * 2008-07-16 2010-09-10 Roquette Freres Procede de fabrication de films directement en alveole.
IT1393331B1 (it) * 2009-02-09 2012-04-20 Graal S R L Composizioni orosolubili e/o effervescenti contenenti almeno un sale di s-adenosilmetionina (same)
EP2243469B1 (fr) 2009-04-22 2012-06-27 Dr. Suwelack Skin & Health Care AG Corps de formage séché par congélation comprenant du phosphate d'ascorbyle de magnésium
BRPI1012170A2 (pt) * 2009-05-20 2016-03-29 Lingual Consegna Pty Ltd formulação e/ou sublingual e método para reduzir a quantidade de composto ativo usado para alcançar um efeito em um paciente em comparação com um composto típico que é ingerido.
WO2011026080A1 (fr) 2009-08-31 2011-03-03 Wilmington Pharmaceuticals, Llc Compositions à désintégration rapide de méloxicame, procédés pour sa fabrication et utilisation pour traiter l'arthrite et/ou la douleur
US20110318411A1 (en) 2010-06-24 2011-12-29 Luber Joseph R Multi-layered orally disintegrating tablet and the manufacture thereof
US8313768B2 (en) 2009-09-24 2012-11-20 Mcneil-Ppc, Inc. Manufacture of tablet having immediate release region and sustained release region
US8871263B2 (en) * 2009-09-24 2014-10-28 Mcneil-Ppc, Inc. Manufacture of tablet in a die utilizing radiofrequency energy and meltable binder
US20110268809A1 (en) 2010-04-28 2011-11-03 Paul Andrew Brinkley Nicotine-Containing Pharmaceutical Compositions
US20110274628A1 (en) 2010-05-07 2011-11-10 Borschke August J Nicotine-containing pharmaceutical compositions
CA2810623A1 (fr) * 2010-09-22 2012-03-29 Christopher E. Szymczak Fabrication de formes pharmaceutiques a densite variable utilisant l'energie de radiofrequence
WO2012039789A1 (fr) * 2010-09-22 2012-03-29 Mcneil-Ppc, Inc. Fabrication de formes pharmaceutiques à densité variable utilisant l'énergie de radiofréquence
CA2810837A1 (fr) * 2010-09-22 2012-03-29 Joseph R. Luber Fabrication de comprimes a partir d'un melange pulverulent auquel de l'energie est appliquee
US8545902B2 (en) 2010-12-15 2013-10-01 Nicholas Lion Dosage forms of plant-derived cathartics
US9084439B2 (en) 2011-09-22 2015-07-21 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US9629392B2 (en) 2011-09-22 2017-04-25 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US9474303B2 (en) 2011-09-22 2016-10-25 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US20130078307A1 (en) 2011-09-22 2013-03-28 Niconovum Usa, Inc. Nicotine-containing pharmaceutical composition
US9907748B2 (en) 2011-10-21 2018-03-06 Niconovum Usa, Inc. Excipients for nicotine-containing therapeutic compositions
US9763928B2 (en) 2012-02-10 2017-09-19 Niconovum Usa, Inc. Multi-layer nicotine-containing pharmaceutical composition
US9044035B2 (en) 2012-04-17 2015-06-02 R.J. Reynolds Tobacco Company Remelted ingestible products
US9445971B2 (en) 2012-05-01 2016-09-20 Johnson & Johnson Consumer Inc. Method of manufacturing solid dosage form
US9511028B2 (en) 2012-05-01 2016-12-06 Johnson & Johnson Consumer Inc. Orally disintegrating tablet
WO2014007780A1 (fr) 2012-07-06 2014-01-09 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Formulations de dexkétoprofène à désintégration orale
WO2014007779A1 (fr) 2012-07-06 2014-01-09 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Formulations de dexkétoprofène à désintégration orale
US20140255452A1 (en) 2013-03-11 2014-09-11 Niconovum Usa, Inc. Method and apparatus for differentiating oral pouch products
WO2015105992A1 (fr) 2014-01-10 2015-07-16 Mcneil-Ppc, Inc. Procédé pour fabriquer un comprimé par radiofréquence et particules revêtues à perte
US9375033B2 (en) 2014-02-14 2016-06-28 R.J. Reynolds Tobacco Company Tobacco-containing gel composition
US20170165252A1 (en) 2015-12-10 2017-06-15 Niconovum Usa Inc. Protein-enriched therapeutic composition
US10493026B2 (en) 2017-03-20 2019-12-03 Johnson & Johnson Consumer Inc. Process for making tablet using radiofrequency and lossy coated particles
WO2019239356A1 (fr) 2018-06-15 2019-12-19 R. J. Reynolds Tobacco Company Purification de nicotine
US20230398079A1 (en) * 2020-10-30 2023-12-14 Dsm Ip Assets B.V. Non-effervescent dissolvable tablets comprising hmos
CN116490194A (zh) * 2020-10-30 2023-07-25 帝斯曼知识产权资产管理有限公司 含hmo的非泡腾可溶性片剂

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2887437A (en) * 1956-08-22 1959-05-19 Pfizer & Co C Palatable vitamin tablet containing an amino acid
US4684534A (en) * 1985-02-19 1987-08-04 Dynagram Corporation Of America Quick-liquifying, chewable tablet
GB8628359D0 (en) * 1986-11-27 1986-12-31 Zyma Sa Galenical formulation
GB8724763D0 (en) * 1987-10-22 1987-11-25 Aps Research Ltd Sustained-release formulations
US4866046A (en) * 1988-05-31 1989-09-12 Top Laboratories, Inc. Low-dosage sublingual aspirin
GB8909793D0 (en) * 1989-04-28 1989-06-14 Beecham Group Plc Pharmaceutical formulation
JP3230814B2 (ja) * 1989-09-15 2001-11-19 シーマ・ラブス、インコーポレイション 炭酸マグネシウムおよびオイルタブレット形成助剤
US5219574A (en) * 1989-09-15 1993-06-15 Cima Labs. Inc. Magnesium carbonate and oil tableting aid and flavoring additive
WO1991004757A1 (fr) * 1989-10-02 1991-04-18 Cima Labs, Inc. Presentation sous forme effervescente d'un medicament a usage pediatrique
US5178878A (en) * 1989-10-02 1993-01-12 Cima Labs, Inc. Effervescent dosage form with microparticles
US5464632C1 (en) * 1991-07-22 2001-02-20 Prographarm Lab Rapidly disintegratable multiparticular tablet
US5466464A (en) * 1991-12-24 1995-11-14 Yamanouchi Pharmaceutical Co., Ltd. Intrabuccally disintegrating preparation and production thereof
US5837285A (en) * 1992-02-18 1998-11-17 Nakamichi; Kouichi Fast soluble tablet
US5330760A (en) * 1992-08-27 1994-07-19 Sterling Winthrop Inc. Effervescent antacid
US5895664A (en) * 1993-09-10 1999-04-20 Fuisz Technologies Ltd. Process for forming quickly dispersing comestible unit and product therefrom
ATE185266T1 (de) * 1994-01-27 1999-10-15 Univ Oklahoma Schnell auflösende orale darreichungsform
US5595761A (en) * 1994-01-27 1997-01-21 The Board Of Regents Of The University Of Oklahoma Particulate support matrix for making a rapidly dissolving tablet
GB9401892D0 (en) * 1994-02-01 1994-03-30 Boots Co Plc Therapeutic agents
US5567439A (en) * 1994-06-14 1996-10-22 Fuisz Technologies Ltd. Delivery of controlled-release systems(s)

Also Published As

Publication number Publication date
ATE260646T1 (de) 2004-03-15
DE69727922T2 (de) 2005-01-20
JP2000508649A (ja) 2000-07-11
HK1016492A1 (en) 1999-11-05
US6083531A (en) 2000-07-04
DE69727922D1 (de) 2004-04-08
WO1997038679A3 (fr) 1997-12-04
TR199802068T2 (xx) 2000-01-21
PT893992E (pt) 2004-06-30
ES2217410T3 (es) 2004-11-01
EP0893992A2 (fr) 1999-02-03
DK0893992T3 (da) 2004-06-01
AU2636797A (en) 1997-11-07
EP0893992B1 (fr) 2004-03-03
WO1997038679A2 (fr) 1997-10-23

Similar Documents

Publication Publication Date Title
ZA973190B (en) Fast melting oral dosage form.
AU1537095A (en) Therapeutic agents containing thyroid hormones
HU9603228D0 (en) Pharmaceutical compositions comprising an opiate antagonist and calcium salts, their use for the treatment of endorphin-mediated pathologies
AU6686596A (en) Pain-alleviating drug composition and method for alleviating pain
IL136285A0 (en) Pharmaceutical compositions containing an acid-labile active component
NZ505193A (en) Opioid agonist/antagonist combinations
NZ333385A (en) Solid oral dosage forms containing 35% of valsartan
IL133397A (en) Pharmaceutical compositions for oral administration comprising an active substance and a cyclodextrin
GEP20053614B (en) Compositions for Oral Administration Containing Opioid Agonist
BG105534A (en) 5ht1 means and method for the treatment of migraine
AU3608295A (en) Process of making dosage units by wet granulation
MX9505064A (es) Composicion farmaceutica, aplicable oralmente.
MX9505065A (es) Composicion farmaceutica, aplicable oralmente.
IL113566A0 (en) Use of certain methanebisphosphonic acid derivatives to prevent prosthesis loosening and prosthesis migration
IL108234A0 (en) Pharmaceutical composition containing galanthamine
CA2325739A1 (fr) Combinaison destinee au traitement de la dependance a l'alcool et aux drogues contenant un antagoniste d'opioides et un modulateur du complexe du recepteur nmda
AU7500794A (en) Novel use of dexmedetomidine
GB9424766D0 (en) Pharmaceutical composition
IL122659A (en) Pharmaceutical compositions for the treatment of dyspeptic symptoms comprising angiotensin ii type receptor antagonists
IL124091A (en) Use of 1-(2-naphth-2-ylethyl)-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine for the preparation of pharmaceutical compositions for the treatment of amyotrophic lateral sclerosis and pharmaceutical compositions containing it
UA41978C2 (uk) N-метил-n-[(1s)-1-феніл-2-((3s)-3-гідроксипіролідин-1-іл)етил]-2,2- дифенілацетамід гідрохлорид, спосіб його отримання та фармацевтична композиція
PL348202A1 (en) Pharmaceutically active composition and dispensing device
SE9501881D0 (sv) New pharmacological use of AII-receptor antagonists
GR3030954T3 (en) Children-proof package for active substance-containing plaster
GEP20043377B (en) Pharmaceutical Complex